journal cover

MicroRNA miR-100 decreases glioblastoma growth by targeting SMARCA5 and ErbB3 in tumor-initiating cells

bioRxiv

Dec 4, 2019

Bahauddeen M AlrfaeiJohn S Kuo

Abstract

Glioblastoma multiforme (GBM) is the most aggressive and most frequently diagnosed malignant human glioma. Despite the best available standard of care (surgery, radiation, and chemotherapy), the median survival of GBM patients is less than 2 years. Many recent studies have indicated tha...read more

Mentioned in this Paper

Biological Markers
Glioblastoma Multiforme
Standard of Care
Study
Tumorigenicity
ERBB3 Receptor Protein-Tyrosine Kinase
AKT1
SMARCA5
NCOR2
Mtor Signaling Pathway BioCarta
1
Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Similar Papers Found In These Feeds

Stem And Cancer Cells (Keystone)

The cancer stem cell theory proposes that, in tumors, there exist a sub-population of cells that possess characteristics of normal stem cells, specifically the ability to self-renew, and that these cells proliferate and sustain the cancer. Here is the latest research on stem and cancer cells.

Glioblastoma Multiforme

Glioblastoma Multiforme (GBM) is a tumor that develops from astrocytes and oligodendrocytes. Here is the latest research on mechanisms that underlie GBM and associated therapeutic approaches.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

BioRxiv Preprints

BioRxiv is the preprint server for biology, operated by Cold Spring Harbor Laboratory. Here are the latest biology preprint articles from bioRxiv.

Stem Cell Tissue Repair

Adult stem cells have been extensively studied for tissue repair and regeneration. Discover the latest research on stem cell tissue repair here.

Stem And Cancer Cells

The cancer stem cell theory proposes that, in tumors, there exist a sub-population of cells that possess characteristics of normal stem cells, specifically the ability to self-renew, and that these cells proliferate and sustain the cancer. Here is the latest research on stem and cancer cells.

Glioma Cells

RNAi & Gene Silencing (Preprints)

RNA Interference (RNAi) pathway is involved in post-transcriptional gene silencing, transcriptional silencing and epigenetic silencing as well as its use as a tool for forward genetics and therapeutics. Discover the latest preprints on RNAi here.

© 2020 Meta ULC. All rights reserved

MicroRNA miR-100 decreases glioblastoma growth by targeting SMARCA5 and ErbB3 in tumor-initiating cells

bioRxiv

Dec 4, 2019

Bahauddeen M AlrfaeiJohn S Kuo

DOI: 10.1101/865105

Abstract

Glioblastoma multiforme (GBM) is the most aggressive and most frequently diagnosed malignant human glioma. Despite the best available standard of care (surgery, radiation, and chemotherapy), the median survival of GBM patients is less than 2 years. Many recent studies have indicated tha...read more

Mentioned in this Paper

Biological Markers
Glioblastoma Multiforme
Standard of Care
Study
Tumorigenicity
ERBB3 Receptor Protein-Tyrosine Kinase
AKT1
SMARCA5
NCOR2
Mtor Signaling Pathway BioCarta
1

Similar Papers Found In These Feeds

Related Papers

Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.
/papers/microrna-mir-100-decreases-glioblastoma-growth-by/990865105